Skip to search.
 FTSE 100 Down 2.44%

AbbVie Inc. (ABBV)

-NYSE
59.77 Down 1.81(2.94%) 4 Sep 21:00
|After Hours: : 59.94 Up 0.17 (0.28%) 5 Sep 00:51
Add to Portfolio
Prev Close:61.58
Open:60.65
Bid:59.57 x 200
Ask:59.95 x 300
1y Target Est:76.93
Beta:1.57619
Earnings Date:29 Oct - 2 Nov (Est.)
Day's Range:58.96 - 60.80
52wk Range:52.06 - 71.60
Volume:9,281,556
Avg Vol (3m):9,311,990
Market Cap:98.94b
P/E (ttm):46.48
EPS (ttm):1.29
Div & Yield:2.04 (3.37%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABBVDown 2.94%98.94b
MRKDown 2.01%145.31b
PFEDown 1.63%193.47b

Key Statistics

Forward P/E (1 yr):11.91
P/S (ttm):4.86
Ex-Dividend Date:13-Jul-15

Analysts

Annual EPS Est (Dec-15) :4.25
Quarterly EPS Est (Sep-15) :1.06
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):0.82

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback